15 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Equianalgesic Chart - Agents ... #Pain #Pharmacology ... #Opioid #Opiate ... Equianalgesics #Conversion ... #Doses #Dosing
OPIOID SWITCHING AND TAPERING.

Long term opioid use results in physical (and potentially psychological) dependence. Opioids should
OPIOID SWITCHING ... NOTE: switching ... pain #tapering #switching ... #pharmacology # ... conversion #management
Table A is a standard conversion of equianalgesic opioids. Many practice sites or text books may
is a standard conversion ... equianalgesic opioids ... reference to use for switching ... #Pharmacology #Pain ... #Opiate #Opioid
Equianalgesic Opioid Dosing 

#Pharmacology #Pain #Opioid #Opiate #Conversion #Equianalgesic #Table
Equianalgesic Opioid ... Dosing #Pharmacology ... #Pain #Opioid # ... Opiate #Conversion
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Initiative (PAMI) - Non-Opioid ... Analgesics - Agents ... and Dosing #Management ... #Pain #Pharmacology ... Medications #Doses #Dosing
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
require unique dosing ... conversions. ... patients taking opiouds ... #Pharmacology #Pain ... #Opiate #Opioid
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
ANTAGONIST (ARB) DOSING ... : TOOL FOR SWITCHING ... BETWEEN AGENTS ... ReceptorBlocker #Pharmacology ... #Conversion #Switching
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... • Neuropathic agents ... Equianalgesia Conversion ... #Conversion #Table ... #agents #internship
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... between oral agents ... the timing and dosing ... oral agents in ... ticagrelor #prasugrel #pharmacology
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... - Switching Between ... inhibitors during ... #conversion #Clopidogrel ... ticagrelor #prasugrel #pharmacology